Literature DB >> 3726155

The stability of prostaglandin E1 in dilute physiological solutions at 37 degrees C.

E W Younger, R M Szabo.   

Abstract

The stability of prostaglandin E1 (PGE1) in three physiologic solutions was studied at body temperature (37 degrees C) over 32 days. The solutions were 100 mcg/ml PGE1 in isotonic saline (pH 4.5), 0.1 M phosphate buffered water (pH 7.4) or 0.01 M phosphate buffered isotonic saline (pH 4.7). PGE1 was found to be more stable in the saline and buffered saline solutions at the pH values of 4.5 and 4.7 respectively. Twenty-five per cent of the PGE1 remained at 32 days in these solutions while 95% of the PGE1 in the solution at pH 7.4 was degraded by day 14. The degradation of PGE1 in the acidic solutions appeared to be nearly linear when plotted on a semilog graph. This data allows one to use PGE1 in an aqueous, slightly acidic solution in a system that requires it to be kept at 37 degrees C for up to 30 days such as a biologically implantable pump. Investigators can use such a system in vivo to study the effect of known concentrations of PGE1 given over a period of time to a specific area of interest.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3726155     DOI: 10.1016/0090-6980(86)90024-9

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  3 in total

1.  Quantitative determination of esterified eicosanoids and related oxygenated metabolites after base hydrolysis.

Authors:  Oswald Quehenberger; Signe Dahlberg-Wright; Jiang Jiang; Aaron M Armando; Edward A Dennis
Journal:  J Lipid Res       Date:  2018-10-15       Impact factor: 5.922

2.  Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size.

Authors:  Beena G Sood; Jennifer Peterson; Monica Malian; Robert Galli; Maria Geisor-Walter; Jon McKinnon; Jody Sharp; Krishna Rao Maddipati
Journal:  Pharmacol Res       Date:  2007-10-02       Impact factor: 7.658

3.  Evaluation of the stability, bioavailability, and hypersensitivity of the omega-3 derived anti-leukemic prostaglandin: Δ(12)-prostaglandin J3.

Authors:  Avinash K Kudva; Naveen Kaushal; Sonia Mohinta; Mary J Kennett; Avery August; Robert F Paulson; K Sandeep Prabhu
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.